102 related articles for article (PubMed ID: 33314199)
1. Modeling the mean time to interval cancer after negative results of periodic cancer screening.
Baker SG
Stat Med; 2021 Mar; 40(6):1429-1439. PubMed ID: 33314199
[TBL] [Abstract][Full Text] [Related]
2. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
[TBL] [Abstract][Full Text] [Related]
3. Overdiagnosis in lung cancer screening: Estimates from the German Lung Cancer Screening Intervention Trial.
González Maldonado S; Motsch E; Trotter A; Kauczor HU; Heussel CP; Hermann S; Zeissig SR; Delorme S; Kaaks R
Int J Cancer; 2021 Mar; 148(5):1097-1105. PubMed ID: 32930386
[TBL] [Abstract][Full Text] [Related]
4. Estimating the frequency of indolent breast cancer in screening trials.
Shen Y; Dong W; Gulati R; Ryser MD; Etzioni R
Stat Methods Med Res; 2019 Apr; 28(4):1261-1271. PubMed ID: 29402176
[TBL] [Abstract][Full Text] [Related]
5. Estimating stage-specific sensitivity for cancer screening tests.
Pinsky P; Lange J; Etzioni R
J Med Screen; 2023 Jun; 30(2):69-73. PubMed ID: 36734139
[TBL] [Abstract][Full Text] [Related]
6. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
7. Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.
Houssami N; Bernardi D; Caumo F; Brunelli S; Fantò C; Valentini M; Romanucci G; Gentilini MA; Zorzi M; Macaskill P
Breast; 2018 Apr; 38():150-153. PubMed ID: 29328943
[TBL] [Abstract][Full Text] [Related]
8. Interval cancers after negative immunochemical test compared to screen and non-responders' detected cancers in Slovenian colorectal cancer screening programme.
Mlakar DN; Bric TK; Škrjanec AL; Krajc M
Radiol Oncol; 2018 Jul; 52(4):413-421. PubMed ID: 30511936
[TBL] [Abstract][Full Text] [Related]
9. A mathematical model of case-ascertainment bias: Applied to case-control studies nested within a randomized screening trial.
Jansen RJ; Alexander BH; Hayes RB; Miller AB; Wacholder S; Church TR
PLoS One; 2018; 13(3):e0194608. PubMed ID: 29554151
[TBL] [Abstract][Full Text] [Related]
10. Trends in lung cancer risk and screening eligibility affect overdiagnosis estimates.
Blom EF; Ten Haaf K; de Koning HJ
Lung Cancer; 2020 Jan; 139():200-206. PubMed ID: 31816564
[TBL] [Abstract][Full Text] [Related]
11. Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme.
Michalopoulos D; Duffy SW
J Med Screen; 2016 Dec; 23(4):192-202. PubMed ID: 26940963
[TBL] [Abstract][Full Text] [Related]
12. Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population Studies.
Gulati R; Feuer EJ; Etzioni R
Am J Epidemiol; 2016 Jul; 184(2):140-7. PubMed ID: 27358266
[TBL] [Abstract][Full Text] [Related]
13. Breast screening using 2D-mammography or integrating digital breast tomosynthesis (3D-mammography) for single-reading or double-reading--evidence to guide future screening strategies.
Houssami N; Macaskill P; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Ciatto S
Eur J Cancer; 2014 Jul; 50(10):1799-1807. PubMed ID: 24746887
[TBL] [Abstract][Full Text] [Related]
14. Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program.
Olsen AH; Agbaje OF; Myles JP; Lynge E; Duffy SW
Breast J; 2006; 12(4):338-42. PubMed ID: 16848843
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and Outcomes of Small Cell Lung Cancer Detected by CT Screening.
Thomas A; Pattanayak P; Szabo E; Pinsky P
Chest; 2018 Dec; 154(6):1284-1290. PubMed ID: 30080997
[TBL] [Abstract][Full Text] [Related]
16. Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.
Wu WY; Törnberg S; Elfström KM; Liu X; Nyström L; Jonsson H
Breast Cancer Res; 2018 Dec; 20(1):153. PubMed ID: 30558679
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
